Moreover, high levels of PRDX6 or SOD1 were associated with a shorter overall survival among MM patients, whereas the expression of GLRX3, GLRX2, TXN, and TXNRD1 did not show any correlation (Figure S3). The gene discussed is PRDX6; the disease is Miyoshi myopathy.